The global seasonal influenza vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is expected to fuel the growth of the market includes an increase in the prevalence of influenza epidemics and seasonal outbreaks. The viral infection which occurs due to flu in the respiratory system is called influenza. The influenza virus travels through respiratory droplets and is contagious. It can also spread from one person to another while talking or due to physical contact. 

Additionally, the influenza virus circulates continuously, causing regional epidemics and outbreaks which leads to thousands of mortalities. The changing character of the virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations globally such as the Centers for Disease Control and Prevention (CDC) have suggested vaccines like baloxavir marboxil (Xofluza) for the treatment of influenza symptoms in patients.

The vaccines used for influenza are made up of three different influenza viruses like influenza type A with H3N2 virus strain, influenza type A with H1N1 virus strain, and influenza type B virus strain. Moreover, an increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the major factors driving the market growth. In addition, an increase in investment by leading market players across the globe and a rise in government funding has facilitated the launch of therapeutically effective vaccines, which is another factor that is expected to augment the growth of the market during the forecast period.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: AstraZeneca plc, CSL Ltd., Emergent BioSolutions Inc., and F. Hoffmann-La Roche AG., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Seasonal Influenza Vaccines Market Report by Segment

By Type 

• Quadrivalent 

• Trivalent

By Virus Type

• Influenza Virus Type A

• Influenza Virus Type B

By Age Group 

• Pediatric

• Adult

Global Seasonal Influenza Vaccines Market by Region